Meta facebook tracking pixel

Listen Now

Topics Covered

  • What’s New from SABCS on: ER, PR and HER2 Positive Breast Cancer, in the Context of COVID-19
  • Updates from SABCS on Diagnostic Testing, Precision Medicine, Grade & Hormone Receptors
  • What’s New in the Standard of Care
  • Updates from SABCS on: Hormone & Targeted Therapy
  • Chemotherapy Updates from SABCS
  • Investigational New Drugs in Clinical Trials
  • What’s New in Prevention & Management of Treatment Side Effects & Long Term Effects
  • The Increasing Role of Telemedicine/Telehealth Appointments
  • Proper Preparation for the Telemedicine/Telehealth Appointments
  • Key Questions from SABCS to Ask Your Healthcare Team about Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts


Julie R. Gralow, MD

Jill Bennett Endowed Professorship in Breast Cancer, Director, Breast Medical Oncology, University of Washington School of Medicine, Director, Breast Medical Oncology, Seattle Cancer Care Alliance


Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University


Sara M. Tolaney, MD, MPH

Associate Director, Susan F. Smith Center for Women’s Cancers, Director, Clinical Trials, Breast Oncology, Senior Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School


Lauren Chatalian, MSW

Women & Children’s Program Manager, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on January 13, 2021.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.